ADT and the Mechanisms of Cardiovascular Disease- E. David Crawford
April 11, 2017
E. David Crawford presents the potential mechanisms for differences in cardiovascular risk with different forms of ADT including; metabolic status, exacerbation of underlying cardiovascular disease (CVD) and preclinical data. In addition, a discussion on the need for the risk of CVD to be assessed prior to the use of ADT.
Additional related content: